Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-22-047041
Filing Date
2022-12-27
Accepted
2022-12-27 16:30:26
Documents
1
Period of Report
2022-12-22

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 5175
  Complete submission text file 0001140361-22-047041.txt   6539
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Issuer) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PLIANT THERAPEUTICS, INC. 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Cummings Keith Lamont (Reporting) CIK: 0001809204 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39303 | Film No.: 221490585